Vol. 25, No. 1, 2014
Miranda et al.
141
64%; m.p. 134 °C; calcd. for C22H17NO4S: C, 67.50; H,
4.38; N, 3.58%; found: C, 67.69; H, 4.51; N, 3.45%;
1H NMR (500 MHz, CD3CN): d 8.12 (t, 2H, J 7.7 Hz),
7.88-7.83 (m, 2H), 7.79 (dt, 1H, J 7.7, 1.3 Hz), 7.39 (dd, 2H,
J 8.8, 2.5 Hz), 7.34 (d, 1H, J 8.8 Hz), 7.32 (d, 1H, J 2.5 Hz),
6.45 (d, 1H, J 9.6 Hz), 2.58 (t, 2H, J 7.2 Hz), 1.44-1.35
Acknowledgements
FAPERJ: PRONEX (grant no. E-26/171.512.2010),
Pensa Rio (grant no. E-26/110.692/2012), JCNE (grant no.
E-26/103.213/ 2011) CNE (grant no. E-26/103.084/2011).
CNPq: M.D.V. and C.M.R. are recipients of research
fellowships and M.O.S. of a PIBIC fellowship. The authors
thank LMQC and Prof J. Walkimar de M. Carneiro and
Jusiane M. Costa for their help with the DFT calculations.
13
(m, 2H), 0.84 (t, 3H, J 7.2 Hz); C NMR-APT (CDCl3,
75 MHz): d 180.8, 180.0, 160.4, 150.7, 144.5, 142.8, 134.7,
134.6, 133.2, 132.8, 130.3, 126.8, 126.6, 126.0, 120.4,
118.7, 118.3, 117.3, 116.9, 45.7, 35.8, 8.50; IR (KBr;
ν
max/cm-1): 3329 (N–H), 3079 (C–Harom.), 2957 (C–Haliph.),
References
1721 (C=Oester), 1658 (C=Oquin.), 1639 (C=Oquin.), 1560
(C=C); UV-Vis [CH3CN; λmax/nm (log ε)]: 281 (4.56), 348
(3.73), 500 (3.54).
1. Hallak, M.; Win, T.; Shpilberg, O.; Bittner, S.; Granot, Y.;
Levy, I.; Nathan, I.; Brit. J. Haematol. 2009, 147, 459.
2. Esteves-Souza, A.; Figueiredo, D. V.; Esteves, A.; Camara,
C. A.; Vargas, M. D.; Pinto, A. C.; Braz. J. Med. Biol. Res.
2007, 40, 1399.
3-(2-oxo-2H-chromen-6-ylamino)-3-(arythiol)
naphthalene-1,4-dione 4and (2-oxo-2H-chromen-6-ylamino)-
3-(4-chloroarythiol) naphthalene-1,4-dione 5: Compounds 4
and 5 were synthesized as described in the literature28 for
analogous compounds 351 mg (1 mmol) of 1 and 1 mmol of
the respective aryl thiols in absolute MeOH (20 mL), under
reflux, in the presence of triethylamine (2.5 mmol). After
8 h, the resulting solution was concentrated under vacuum
and purified by column chromatography on silica gel using
EtOAc/hexane. 4: yield: 317 mg, 77%; m.p. 240 °C; calcd.
for C24H15NO4S: C, 69.72; H, 3.66; N, 3.39%.; found: C,
67.88; H, 3.52; N, 3.30%; 1H NMR (DMSO-d6, 500 MHz):
d 8.20 (d, 1H, J 7.6 Hz), 8.13 (d, 1H, J 7.6 Hz), 7.99 (t, 1H,
J 7.4 Hz), 7.95 (d, 1H, J 7.4 Hz), 7.91 (d, 1H, J 9.5 Hz),
7.25-7.23 (m, 1H), 7.19-7.16 (m, 5H), 6.86 (d, 1H, J 7.3 Hz),
6.85 (d, 1H, J 5.9 Hz), 6.54 (d, 1H, J 9.5 Hz); IR (KBr;
3. Esteves-Souza, A.; Lúcio, K. A.; Cunha, A. S.; Pinto, A. C.;
Lima, E. L. S.; Camara, C. A.; Vargas, M. D.; Gattass, C. R.;
Onc. Rep. 2008, 20, 225.
4. Francisco, A. I.; Casellato, A.; Neves, A. P.; Carneiro, J. W.
D; Vargas, M. D.; Visentin, L. C.; Magalhães, A.; Camara, C.
A.; Pessoa, C; Costa-Lotufo, L. V.; Marinho, J. D. B.; Moraes,
M. O.; J. Braz. Chem. Soc. 2010, 21, 169.
5. Barbosa, T. P.; Camara, C. A.; Silva, T. M. S.; Martins, R. M.;
Pinto,A. C.;Vargas, M. D.; Bioorg. Med. Chem. 2005, 13, 6464.
6. Silva, T. M. S.; Camara, C. A.; Barbosa, T. P.; Soares, A. Z.;
Cunha, L. C.; Pinto, A. C.; Vargas, M. D.; Bioorg. Med. Chem.
2005, 13, 193.
7. Kapadia, G. J.;Azuine, M.A.; Balasubramanian,V.; Sridhar, R.;
Pharmacol. Res. 2001, 43, 363.
ν
max/cm-1): 3306 (N–H), 3080 (C–Harom.), 1733 (C=Oester),
8. Ryu, C.-K.; Kim, D.-H.; Arch. Pharm. Res. 1992, 15, 263.
9. Clark, N. G.; Pest. Sci. 1985, 16, 23.
1678 (C=Oquin.), 1664 (C=Oquin.), 1551 (C=C); UV-Vis
[CH3CN; λmax/nm (log ε)]: 284 (4.47), 505 (3.39). 5: yield:
365 mg, 82%; m.p. 210 °C; calcd. for C24H14ClNO4S: C,
64.36; H, 3.15; N, 3.13%.; found: C, 62.58; H, 3.24; N,
10. Koura, S.; Takasuka, K.; Katsuyama, N.; Ogino, C.; Sato, Y.;
Wakabayashi, K.; Biosc. Biotech. Biochem. 1994, 58, 1210.
11. Silveira, G. Q.; Ronconi, C. M.;Vargas, M. D.; San Gil, R.A. S.;
Magalhães, A.; J. Braz. Chem. Soc. 2011, 22, 961.
12. Glezer, V.; Stradins, J.; Friemanis, J.; Baider, L.; Electrochim.
Acta 1983, 28, 87.
1
3.03%; H NMR (DMSO-d6, 500 MHz): d 8.20 (d, 1H,
J 7.6 Hz), 8.13 (d, 1H, J 7.6 Hz), 7.99 (t, 1H, J 7.4 Hz),
7.96-7.92 (m, 2H), 7.26 (d, 1H, J 9.5 Hz), 7.22-7.19 (m,
4H), 6.88 (d, 2H, J 8.6 Hz), 6.56 (d, 1H, J 9.5 Hz); IR (KBr;
13. Aguilar-Martínez, M.; Cuevas, G.; Jiménez-Estrada, M.;
González, I.; Lotina-Hennsen, B.; Macías-Ruvalcaba, N.;
J. Org. Chem. 1999, 64, 3684.
ν
max/cm-1): 3267 (N–H), 3079 (C–Harom.), 1742 (C=Oester),
1663 (C=Oquin.), 1627 (C=Oquin.), 1537 (C=C); UV-Vis
[CH3CN; λmax/nm (log ε)]: 282 (4.29), 510 (3.15).
14. Koyama, J.; Morita, I.; Kobayashi, N.; Osakai, T.; Hotta, H.;
Takayasu, J.; Nishino, H.; Tokuda, H.; Cancer Lett. 2003, 201,
25.
Supplementary information
15. Brun, M. P.; Braud, E.;Angotti, D.; Mondésert, O.; Quaranta, M.;
Montes, M.; Miteva, M.; Gres, N.; Ducommun, B.; Garbay, C.;
Bioorg. Med. Chem. 2005, 13, 4871.
Supplementary Information associated with the paper
contains FTIR, 1H, 13C NMR spectra, cyclic voltammograms
of the compounds and computational details. These data
PDF file.
16. Katritzky, A. R.; Narindoshvili, T.; Org. Biomol. Chem. 2009,
7, 627.
17. Krueger, A. T.; Imperiali, B.; Chembiochem. 2013, 14, 788.